×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Bolt Biotherapeutics Inc. (BOLT) NASDAQ

$1.40 0.18 (14.75%)

Market Cap: $53.38M

As of 03/28/24 04:00 PM EDT. Market closed.

(BOLT)

Bolt Biotherapeutics Inc. (BOLT)
NASDAQ

$1.40
0.18 (14.75%)

Market Cap: $53.38M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to ... read more

bolt biotherapeutics is a start-up with compelling technology from dr. engleman’s lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company’s future leaders to help it further develop and bring to patients novel and curative biotherapies. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
640 Galveston Drive, California, Redwood City, 94063.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
640 Galveston Drive, California, Redwood City, 94063.
PRICE CHART FOR BOLT BIOTHERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.22
Previous Close
$1.22
Days Range
$1.22 - $1.47
52 week range
$0.84 - $2.03
Volume
558,202
Avg. Volume (30 days)
172,107
Market Cap
$53.38M
Dividend Yield
-
P/E
(0.77)
Shares Outstanding
38,127,740
Open
$1.22
Previous Close
$1.22
Days Range
$1.22 - $1.47
52 week range
$0.84 - $2.03
Volume
558,202
Avg. Volume (30 days)
172,107
Market Cap
$53.38M
Dividend Yield
-
P/E
(0.77)
Shares Outstanding
38,127,740
FINANCIAL STATEMENTS FOR BOLT BIOTHERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BOLT BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Quinn William P.Chief Financial OfficerDec 12, 2023 Buy$0.957,5007,12536,272Dec 13, 2023, 01:40 PM
Quinn William P.Chief Financial OfficerDec 06, 2023 Buy$0.782,5001,95528,772Dec 13, 2023, 01:40 PM
Quinn William P.Chief Financial OfficerJun 06, 2023 Buy$1.181,8292,16126,272Dec 13, 2023, 01:40 PM
ENGLEMAN EDGARDirectorNov 30, 2023 Sale$0.8614,93412,815251,522Dec 01, 2023, 12:31 PM
ENGLEMAN EDGARDirectorNov 29, 2023 Sale$0.913,1312,837266,456Dec 01, 2023, 12:31 PM
ENGLEMAN EDGARDirectorNov 30, 2023 Sale$0.86108,14592,7991,821,483Dec 01, 2023, 12:31 PM
ENGLEMAN EDGARDirectorNov 29, 2023 Sale$0.9122,67420,5431,929,628Dec 01, 2023, 12:31 PM
ENGLEMAN EDGARDirectorNov 21, 2023 Sale$0.90236213269,587Nov 22, 2023, 07:45 PM
ENGLEMAN EDGARDirectorNov 21, 2023 Sale$0.901,7071,5391,952,302Nov 22, 2023, 07:45 PM
Vivo Capital VIII, LLC10% OwnerNov 21, 2023 Sale$0.901,4571,311111,662Nov 22, 2023, 06:51 PM
Vivo Capital VIII, LLC10% OwnerNov 21, 2023 Sale$0.90236212269,587Nov 22, 2023, 06:51 PM
Vivo Capital VIII, LLC10% OwnerNov 21, 2023 Sale$0.901,7071,5361,952,302Nov 22, 2023, 06:51 PM
ENGLEMAN EDGARDirectorNov 20, 2023 Sale$0.9227,46525,2681,954,009Nov 20, 2023, 09:31 PM
ENGLEMAN EDGARDirectorNov 17, 2023 Sale$0.938,2117,6361,981,474Nov 20, 2023, 09:31 PM
ENGLEMAN EDGARDirectorNov 16, 2023 Sale$0.967,5317,2301,989,685Nov 20, 2023, 09:31 PM
ENGLEMAN EDGARDirectorNov 20, 2023 Sale$0.923,7923,489269,823Nov 20, 2023, 09:31 PM
ENGLEMAN EDGARDirectorNov 17, 2023 Sale$0.931,1341,055273,615Nov 20, 2023, 09:31 PM
ENGLEMAN EDGARDirectorNov 16, 2023 Sale$0.961,040998274,749Nov 20, 2023, 09:31 PM
Vivo Capital VIII, LLC10% OwnerNov 17, 2023 Sale$0.931,1341,055273,615Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 17, 2023 Sale$0.938,2117,6361,981,474Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 16, 2023 Sale$0.966,4296,172143,571Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 20, 2023 Sale$0.9223,44321,568113,119Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 16, 2023 Sale$0.961,040998274,749Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 20, 2023 Sale$0.923,7923,489269,823Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 16, 2023 Sale$0.967,5317,2301,989,685Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 20, 2023 Sale$0.9227,46525,2681,954,009Nov 20, 2023, 09:09 PM
Vivo Capital VIII, LLC10% OwnerNov 17, 2023 Sale$0.937,0096,518136,562Nov 20, 2023, 09:09 PM
Novo Holdings A/S10% OwnerJul 13, 2022 Sale$2.00800,0001,600,0003,703,991Jul 15, 2022, 04:16 PM
Perez Edith A.Chief Medical OfficerDec 22, 2021 Option Exercise$2.8035,71499,99937,042Feb 01, 2022, 07:18 PM
Perez Edith A.Chief Medical OfficerDec 06, 2021 Buy$4.644111,9071,328Feb 01, 2022, 07:18 PM
Perez Edith A.Chief Medical OfficerJun 04, 2021 Buy$16.6591715,268917Feb 01, 2022, 07:18 PM
Quinn William P.Chief Financial OfficerDec 08, 2021 Buy$4.725,00023,57520,154Dec 09, 2021, 04:05 PM
Quinn William P.Chief Financial OfficerDec 06, 2021 Buy$4.643516215,154Dec 09, 2021, 04:05 PM
Quinn William P.Chief Financial OfficerJun 04, 2021 Buy$16.651,22120,33015,119Dec 09, 2021, 04:05 PM
Novo Holdings A/S10% OwnerFeb 09, 2021 Buy$20.00400,0008,000,0004,503,991Feb 11, 2021, 04:39 PM
Sofinnova Venture Partners X, L.P.10% OwnerFeb 09, 2021 Buy$20.00450,0009,000,0002,754,437Feb 09, 2021, 06:04 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Buy$20.00150,0003,000,000150,000Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Buy$20.0024,267485,340275,789Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Buy$20.00175,7333,514,6601,997,216Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Sale$20.001442,8801,821,483Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Sale$20.00621,2401,448,286Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Sale$20.0020400251,522Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Option Exercise$0.0740,9532,8671,821,627Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Option Exercise$0.0717,7111,2401,448,348Feb 09, 2021, 03:37 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Option Exercise$0.075,655396251,542Feb 09, 2021, 03:37 PM
LAPORTE KATHLEENDirectorFeb 09, 2021 Buy$20.001,20024,0001,200Feb 09, 2021, 03:35 PM
SHAH MAHENDRADirectorFeb 09, 2021 Sale$20.00621,2401,448,286Feb 09, 2021, 03:33 PM
SHAH MAHENDRADirectorFeb 09, 2021 Option Exercise$0.0717,7111,2401,448,348Feb 09, 2021, 03:33 PM
HEALY JAMESDirectorFeb 09, 2021 Buy$20.00450,0009,000,0002,754,437Feb 09, 2021, 03:29 PM
Khanna Ashish Siri RamDirectorFeb 09, 2021 Buy$20.001,20024,0001,200Feb 09, 2021, 03:27 PM
Khanna Ashish Siri RamDirectorFeb 09, 2021 Buy$20.001,00020,0001,000Feb 09, 2021, 03:27 PM
ENGLEMAN EDGARDirectorFeb 09, 2021 Buy$20.00175,7333,514,6601,997,216Feb 09, 2021, 03:25 PM
ENGLEMAN EDGARDirectorFeb 09, 2021 Buy$20.0024,267485,340275,789Feb 09, 2021, 03:25 PM
ENGLEMAN EDGARDirectorFeb 09, 2021 Sale$20.001442,8801,821,483Feb 09, 2021, 03:25 PM
ENGLEMAN EDGARDirectorFeb 09, 2021 Sale$20.0020400251,522Feb 09, 2021, 03:25 PM
ENGLEMAN EDGARDirectorFeb 09, 2021 Option Exercise$0.0740,9532,8671,821,627Feb 09, 2021, 03:25 PM
ENGLEMAN EDGARDirectorFeb 09, 2021 Option Exercise$0.075,655396251,542Feb 09, 2021, 03:25 PM
Quinn William P.Chief Financial OfficerFeb 09, 2021 Buy$20.001,20024,00013,898Feb 09, 2021, 03:23 PM
Schatzman Randall CChief Executive OfficerFeb 09, 2021 Buy$20.001,50030,0001,500Feb 09, 2021, 03:20 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Quinn William P.Chief Financial Officer12/12/20237,125
Quinn William P.Chief Financial Officer12/06/20231,955
Quinn William P.Chief Financial Officer06/06/20232,161
ENGLEMAN EDGARDirector11/30/202312,815
ENGLEMAN EDGARDirector11/29/20232,837
ENGLEMAN EDGARDirector11/30/202392,799
ENGLEMAN EDGARDirector11/29/202320,543
ENGLEMAN EDGARDirector11/21/2023213
ENGLEMAN EDGARDirector11/21/20231,539
Vivo Capital VIII, LLC10% Owner11/21/20231,311
Vivo Capital VIII, LLC10% Owner11/21/2023212
Vivo Capital VIII, LLC10% Owner11/21/20231,536
ENGLEMAN EDGARDirector11/20/202325,268
ENGLEMAN EDGARDirector11/17/20237,636
ENGLEMAN EDGARDirector11/16/20237,230
ENGLEMAN EDGARDirector11/20/20233,489
ENGLEMAN EDGARDirector11/17/20231,055
ENGLEMAN EDGARDirector11/16/2023998
Vivo Capital VIII, LLC10% Owner11/17/20231,055
Vivo Capital VIII, LLC10% Owner11/17/20237,636
Vivo Capital VIII, LLC10% Owner11/16/20236,172
Vivo Capital VIII, LLC10% Owner11/20/202321,568
Vivo Capital VIII, LLC10% Owner11/16/2023998
Vivo Capital VIII, LLC10% Owner11/20/20233,489
Vivo Capital VIII, LLC10% Owner11/16/20237,230
Vivo Capital VIII, LLC10% Owner11/20/202325,268
Vivo Capital VIII, LLC10% Owner11/17/20236,518
Novo Holdings A/S10% Owner07/13/20221,600,000
Perez Edith A.Chief Medical Officer12/22/202199,999
Perez Edith A.Chief Medical Officer12/06/20211,907
Perez Edith A.Chief Medical Officer06/04/202115,268
Quinn William P.Chief Financial Officer12/08/202123,575
Quinn William P.Chief Financial Officer12/06/2021162
Quinn William P.Chief Financial Officer06/04/202120,330
Novo Holdings A/S10% Owner02/09/20218,000,000
Sofinnova Venture Partners X, L.P.10% Owner02/09/20219,000,000
Vivo Capital VIII, LLC10% Owner02/09/20213,000,000
Vivo Capital VIII, LLC10% Owner02/09/2021485,340
Vivo Capital VIII, LLC10% Owner02/09/20213,514,660
Vivo Capital VIII, LLC10% Owner02/09/20212,880
Vivo Capital VIII, LLC10% Owner02/09/20211,240
Vivo Capital VIII, LLC10% Owner02/09/2021400
Vivo Capital VIII, LLC10% Owner02/09/20212,867
Vivo Capital VIII, LLC10% Owner02/09/20211,240
Vivo Capital VIII, LLC10% Owner02/09/2021396
LAPORTE KATHLEENDirector02/09/202124,000
SHAH MAHENDRADirector02/09/20211,240
SHAH MAHENDRADirector02/09/20211,240
HEALY JAMESDirector02/09/20219,000,000
Khanna Ashish Siri RamDirector02/09/202124,000
Khanna Ashish Siri RamDirector02/09/202120,000
ENGLEMAN EDGARDirector02/09/20213,514,660
ENGLEMAN EDGARDirector02/09/2021485,340
ENGLEMAN EDGARDirector02/09/20212,880
ENGLEMAN EDGARDirector02/09/2021400
ENGLEMAN EDGARDirector02/09/20212,867
ENGLEMAN EDGARDirector02/09/2021396
Quinn William P.Chief Financial Officer02/09/202124,000
Schatzman Randall CChief Executive Officer02/09/202130,000
Load More Insider Transactions
FUNDS WITH A POSITION IN BOLT BIOTHERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC3,521,2910.32%-9.04%Other
ORBIMED ADVISORS LLC1,541,0000.03%No changeOther
ADAGE CAPITAL PARTNERS GP, L.L.C.500,0000.00116%No changeOther
RENAISSANCE TECHNOLOGIES LLC445,2730.00077%41.72%Other
GEODE CAPITAL MANAGEMENT, LLC350,1640.00004%-2.93%Other
BLACKROCK INC.257,2710.00001%-0.29%Other
CHANGE IN SHARES OUTSTANDING FOR BOLT BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR BOLT BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.20%
1Q
12/31/2023
06/30/2023
0.51%
2Q
12/31/2023
03/31/2023
0.69%
3Q
12/31/2023
12/31/2022
1.03%
4Q
12/31/2023
09/30/2022
1.30%
5Q
12/31/2023
06/30/2022
1.74%
6Q
12/31/2023
03/31/2022
2.20%
7Q
12/31/2023
12/31/2021
1.68%
8Q
12/31/2023
09/30/2021
1.98%
9Q
12/31/2023
06/30/2021
3.68%
10Q
12/31/2023
03/31/2021
76.49%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.20%
1Q
06/30/2023
0.51%
2Q
03/31/2023
0.69%
3Q
12/31/2022
1.03%
4Q
09/30/2022
1.30%
5Q
06/30/2022
1.74%
6Q
03/31/2022
2.20%
7Q
12/31/2021
1.68%
8Q
09/30/2021
1.98%
9Q
06/30/2021
3.68%
10Q
03/31/2021
76.49%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR BOLT BIOTHERAPEUTICS INC
LOADING...